Alle Fälle anzeigen
UPC APP 25212/2025
—·EP2279254 +1 more: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieSonstige prozessuale
- Parteien
- Beklagte
- Moderna, Inc.
- ModernaTX, Inc.
- Moderna Switzerland GmbH
- Moderna Netherlands B.V.
- Moderna Biotech Spain SL
- Moderna Germany GmbH
- Moderna France SASU
- Moderna Italy S.R.L.
- Moderna Belgium S.R.L.
- Moderna Denmark ApS
- Moderna Sweden AB
- Moderna Norway AS
- Moderna Portugal Unipessoal LDA
- Moderna Poland SP. Z.O.O.
- Moderna Biotech UK Limited
Vertreter: Ruben Laddé; Joachim Renken - Division
- The Hague LD
- Richter
- Margot Kokke · Judge-rapporteur
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 4. Juni 2025
Entscheidungen
- 2025-06-04Generic application
The Hague Local Division issued a rectification order under R.353 RoP correcting clerical errors in a prior procedural order regarding the dates of service on Moderna Germany, Belgium, and Poland, thereby rendering Moderna's preliminary objections admissible for all defendants in infringement actions concerning EP2279254 and EP4241767.
Rechtsfragen:Rectification of order (R.353 RoP)Clerical errors in date of serviceAdmissibility of preliminary objectionsTime limit for preliminary objections
Dokumente
- 3A6CB666B2346F48F42C2C1ED8EB1D9B_en.pdf2025-06-04EN